YARDLEY, Pa., Dec. 15, 2021 /PRNewswire/ -- Herspiegel
Consulting, LLC., a full-service life science consulting firm that
specializes in commercial strategy and execution, announced today
that it has received a growth investment from DFW Capital Partners
("DFW"). The size of the investment was not disclosed.
Herspiegel Consulting receives investment from DFW Capital Partners
to accelerate growth.
Founded in 2007, Herspiegel Consulting advises start-ups to
Fortune 100 pharmaceutical clients on commercial projects across a
diverse array of service offerings including product launch
readiness, marketing, market access, medical affairs, and patient
services. This investment will accelerate Herspiegel Consulting's
growth trajectory, enabling it to expand geographically and in the
scope and types of services it offers its clients, as it continues
to build on its industry-leading capabilities and reach.
"Herspiegel is rapidly accelerating its growth and with this
investment from DFW, we will be extremely well positioned to grow
our offerings for our clients and expand into new geographic
markets," Brent Herspiegel, CEO,
Herspiegel Consulting, said.
Beth Schurman, Chief Operating
Officer, Herspiegel, added, "Our clients are grappling with complex
commercial strategy and execution issues in the pharmaceutical
industry and this investment will help us better serve their
constantly evolving needs."
DFW Operating Partner Kurt
Brykman, who possesses deep pharmaceutical consulting
experience and previously served in leadership roles with PAREXEL
Consulting, Kinapse and Medpace, will join Herspiegel Consulting's
Board of Directors.
"Herspiegel Consulting has built an impressive team and a
market-leading position in product commercialization with expertise
across primary and specialty care, rare disease, oncology, and cell
and gene therapy," DeVer Warner,
Partner at DFW, said. "They have demonstrated a strong culture of
quality and commercial expertise to meet the increasingly complex
needs of pharmaceutical and biotech clients and we are excited to
partner with the company to drive its continued rapid
growth."
About Herspiegel Consulting
Herspiegel Consulting is a leading full-service consulting firm
that specializes in the pharmaceutical, biotech, and medical device
industries. We help our clients define impactful strategic
approaches, streamline launch and commercialization processes,
enhance business intelligence, and optimize product performance.
Our service offerings include strategy and execution in launch
readiness, marketing, market access, medical affairs,
and patient services. Herspiegel Consulting clients span
start-ups executing first commercialization to Fortune 500
pharmaceutical with projects across primary care, oncology, and
rare disease. https://www.herspiegelconsulting.com/
Media Contact
Phil
LeClare
Magnetude Consulting on behalf Herspiegel Consulting
phil@magnetudeconsulting.com
617-209-9406
View original
content:https://www.prnewswire.com/news-releases/herspiegel-consulting-closes-growth-investment-from-dfw-capital-partners-301445485.html
SOURCE Herspiegel Consulting